Articles

Highlights in multiple myeloma

BJH - volume 13, issue 5, september 2022

J. Blokken PhD, PharmD, T. Feys MBA, MSc

SUMMARY

During the past European Hematology Association’s annual congress (EHA 2022), four oral sessions were devoted to clinical trials and recent advances in myeloma. These sessions covered newly diagnosed multiple myeloma (MM), antibody-based therapy in relapsed/refractory (RR) MM, BCMA-directed treatment in RRMM and biology and translational research. Below, we summarise the highlights from some of the studies that were presented in each of these sessions.

(BELG J HEMATOL 2022;13(5):219–23)

Read more

Journal scan

BJH - volume 13, issue 4, june 2022

J. Blokken PhD, PharmD, T. Feys MBA, MSc

SUMMARY

In this section of the Belgian Journal of Hematology (BJH), we aim to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on haematology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjh.be) and we will make sure to include it in the journal scan section of the next BJH issue.

(BELG J HEMATOL 2022;13(4):175–8)

Read more

New haematology reimbursements in Belgium

BJH - volume 13, issue 4, june 2022

T. Feys MBA, MSc

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2022;13(4):174)

Read more

Presidential symposium EBMT 2022

BJH - volume 13, issue 4, june 2022

A. Enguita PhD, T. Feys MBA, MSc

SUMMARY

During the presidential symposium of the 48th Annual Meeting of the EBMT (2022), the Van Bekkum Award and seven top clinical abstracts were discussed. These presentations will be covered in this report.

(BELG J HEMATOL 2022;13(4):169–73)

Read more

Highlights from EAHAD 2022

BJH - volume 13, issue 3, may 2022

T. Feys MBA, MSc

SUMMARY

From 1–4 February 2022, more than 2,300 delegates joined and interacted online during the 2022 European Association for Haemophilia and Allied Disorders (EAHAD) Virtual Congress. During these days, EAHAD 2022 was once again the virtual ‘place-to-be’ for the latest in the field of haemophilia and allied disorders.

(BELG J HEMATOL 2022;13(3):133–6)

Read more

Journal scan

BJH - volume 13, issue 3, may 2022

J. Blokken PhD, PharmD, T. Feys MBA, MSc

SUMMARY

In this section of the Belgian Journal of Hematology (BJH), we aim to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on haematology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjh.be) and we will make sure to include it in the journal scan section of the next BJH issue.

(BELG J HEMATOL 2022;13(3):137–40)

Read more

Journal scan

BJH - volume 13, issue 2, march 2022

J. Blokken PhD, PharmD, T. Feys MBA, MSc

In this section of the BJH, we aim to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on haematology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjh.be) and we will make sure to include it in the journal scan section of the next BJH issue.

(BELG J HEMATOL 2022;13(2):101–3)

Read more
X